Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

10.44
-0.0700-0.67%
Volume:290.42K
Turnover:3.04M
Market Cap:178.58M
PE:-2.71
High:10.74
Open:10.44
Low:10.28
Close:10.51
52wk High:16.77
52wk Low:10.28
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.55
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.83
PE(LYR):-3.27

Loading ...

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

GlobeNewswire
·
May 19

Circio touts potent circRNA platform with dose-cutting promise at ASGCT

TIPRANKS
·
May 16

Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says

MT Newswires Live
·
May 16

Avidity Biosciences Initiated at Outperform by Leerink Partners

Dow Jones
·
May 16

Atrium Therapeutics initiated with an Outperform at Leerink

TIPRANKS
·
May 15

Atrium Therapeutics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $25

THOMSON REUTERS
·
May 15

Corrected-Atrium Therapeutics Inc Q1 Operating Income USD -17.28 Million (Correct Source, Adds Ric)

THOMSON REUTERS
·
May 15

Corrected-Atrium Therapeutics Inc Q1 Operating Expenses USD 36.915 Million (Correct Source, Adds Ric)

THOMSON REUTERS
·
May 15

Atrium Therapeutics Q1 FY26 net loss widens to $16.63 million; revenue rises to $19.64 million

Reuters
·
May 15

Atrium Therapeutics Q1 collaboration revenue surges after spin-off

Reuters
·
May 15

Atrium Therapeutics Q1 EPS $(0.97) Beats $(1.10) Estimate, Sales $19.635M Beat $2.000M Estimate

Benzinga Earnings
·
May 15

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

prnewswire
·
May 14

EVEREST MED Shares Climb Over 3% Following Release of Initial Human Data for mRNA Cancer Vaccine EVM16

Stock News
·
May 14

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

GlobeNewswire
·
May 14

Thalia Therapeutics CEO Outlines Strategic Pivot to High-Value RNA Therapies

TIPRANKS
·
May 13

Capital Universities Strengthen Role as Pillars in Fundamental Research

Deep News
·
May 13

Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

GlobeNewswire
·
May 12

ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances

TIPRANKS
·
May 12

ProQR Announces First Quarter 2026 Operating and Financial Results

GlobeNewswire
·
May 12

ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform

GlobeNewswire
·
May 11